The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment
MEK 抑制剂 Selumetinib 通过重新编程肿瘤免疫微环境来补充 CTLA-4 阻断
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1186/s40425-017-0268-8
Edmund Poon, Stefanie Mullins, Amanda Watkins, Geoffrey S Williams, Jens-Oliver Koopmann, Gianfranco Di Genova, Marie Cumberbatch, Margaret Veldman-Jones, Shaun E Grosskurth, Vasu Sah, Alwin Schuller, Corrine Reimer, Simon J Dovedi, Paul D Smith, Ross Stewart, Robert W Wilkinson
